Literature DB >> 24578173

Caveolin-1 deficiency may predispose African Americans to systemic sclerosis-related interstitial lung disease.

Charles Reese1, Beth Perry, Jonathan Heywood, Michael Bonner, Richard P Visconti, Rebecca Lee, Corey M Hatfield, Richard M Silver, Stanley Hoffman, Elena Tourkina.   

Abstract

OBJECTIVE: Interstitial lung disease (ILD) is the leading cause of death in patients with systemic sclerosis (SSc; scleroderma). Although SSc-related ILD is more common and severe in African Americans than in Caucasians, little is known about factors underlying this significant health disparity. The aim of this study was to examine the role that low expression of caveolin-1 might play in susceptibility to ILD among African Americans.
METHODS: Assays of monocyte migration toward stromal cell-derived factor 1 (SDF-1) were performed using monocytes from Caucasian and African American healthy donors and patients with SSc. For fibrocyte differentiation studies, total peripheral blood mononuclear cells were incubated on fibronectin-coated plates. Protein expression was evaluated by immunohistochemistry and Western blotting.
RESULTS: Monocytes from healthy African American donors and those from patients with SSc had low caveolin-1 levels, enhanced migration toward the CXCR4 ligand SDF-1, and enhanced differentiation to fibrocytes. Enhanced migration and differentiation of monocytes from African Americans and patients with SSc appeared to be attributable to the lack of caveolin-1, because restoring caveolin-1 function using a caveolin-1 scaffolding domain peptide inhibited these processes. Although they differed from monocytes from Caucasians, monocytes from both African Americans and patients with SSc were not identical, because SSc monocytes showed major increases from baseline in ERK, JNK, p38, and Smad2/3 activation, while monocytes from African Americans showed only limited ERK activation and no activation of JNK, p38, or Smad2/3. In contrast, SDF-1 exposure caused no additional ERK activation in SSc monocytes but did cause significant additional activation in monocytes from African Americans.
CONCLUSION: African Americans may be predisposed to SSc-related ILD due to low baseline caveolin-1 levels in their monocytes, potentially affecting signaling, migration, and fibrocyte differentiation. The monocytes of African Americans may lack caveolin-1 due to high levels of transforming growth factor β in their blood.
Copyright © 2014 by the American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24578173      PMCID: PMC4158912          DOI: 10.1002/art.38572

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN: 2326-5191            Impact factor:   10.995


  44 in total

1.  Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease.

Authors:  Borna Mehrad; Marie D Burdick; David A Zisman; Michael P Keane; John A Belperio; Robert M Strieter
Journal:  Biochem Biophys Res Commun       Date:  2006-12-11       Impact factor: 3.575

2.  Caveolin interaction with protein kinase C. Isoenzyme-dependent regulation of kinase activity by the caveolin scaffolding domain peptide.

Authors:  N Oka; M Yamamoto; C Schwencke; J Kawabe; T Ebina; S Ohno; J Couet; M P Lisanti; Y Ishikawa
Journal:  J Biol Chem       Date:  1997-12-26       Impact factor: 5.157

3.  Loss of caveolin expression in type I pneumocytes as an indicator of subcellular alterations during lung fibrogenesis.

Authors:  M Kasper; T Reimann; U Hempel; K W Wenzel; A Bierhaus; D Schuh; V Dimmer; G Haroske; M Müller
Journal:  Histochem Cell Biol       Date:  1998-01       Impact factor: 4.304

4.  Systemic sclerosis mortality in the United States: 1979-1998.

Authors:  Eswar Krishnan; Daniel E Furst
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

5.  Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover.

Authors:  Gianni M Di Guglielmo; Christine Le Roy; Anne F Goodfellow; Jeffrey L Wrana
Journal:  Nat Cell Biol       Date:  2003-05       Impact factor: 28.824

Review 6.  Scleroderma epidemiology.

Authors:  Maureen D Mayes
Journal:  Rheum Dis Clin North Am       Date:  2003-05       Impact factor: 2.670

7.  Antifibrotic properties of caveolin-1 scaffolding domain in vitro and in vivo.

Authors:  Elena Tourkina; Mathieu Richard; Pal Gööz; Michael Bonner; Jaspreet Pannu; Russell Harley; Pascal N Bernatchez; William C Sessa; Richard M Silver; Stanley Hoffman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-01-18       Impact factor: 5.464

8.  Patterns of hospital admissions and emergency room visits among patients with scleroderma in South Carolina, USA.

Authors:  Paul J Nietert; Richard M Silver
Journal:  J Rheumatol       Date:  2003-06       Impact factor: 4.666

9.  Ethnic disparities among patients with pulmonary hypertension associated with systemic sclerosis.

Authors:  Ashley D Beall; Paul J Nietert; Marian H Taylor; Holly C Mitchell; Stephanie R Shaftman; Richard M Silver; Edwin A Smith; Marcy B Bolster
Journal:  J Rheumatol       Date:  2007-05-15       Impact factor: 4.666

10.  A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis.

Authors:  Virginia Steen; Robyn T Domsic; Mary Lucas; Noreen Fertig; Thomas A Medsger
Journal:  Arthritis Rheum       Date:  2012-09
View more
  15 in total

Review 1.  Evolving insights into the cellular and molecular pathogenesis of fibrosis in systemic sclerosis.

Authors:  Benjamin Korman
Journal:  Transl Res       Date:  2019-02-23       Impact factor: 7.012

2.  Reversal of maladaptive fibrosis and compromised ventricular function in the pressure overloaded heart by a caveolin-1 surrogate peptide.

Authors:  Dorea Pleasant-Jenkins; Charles Reese; Panneerselvem Chinnakkannu; Harinath Kasiganesan; Elena Tourkina; Stanley Hoffman; Dhandapani Kuppuswamy
Journal:  Lab Invest       Date:  2017-01-23       Impact factor: 5.662

Review 3.  Epigenetics of scleroderma: Integrating genetic, ethnic, age, and environmental effects.

Authors:  Paula S Ramos
Journal:  J Scleroderma Relat Disord       Date:  2019-07-03

4.  Ethnic differences in TGFβ-signaling pathway may contribute to prostate cancer health disparity.

Authors:  Bethtrice Elliott; DeAdra L Zackery; Vanessa A Eaton; Re'Josef T Jones; Fisseha Abebe; Camille C Ragin; Shafiq A Khan
Journal:  Carcinogenesis       Date:  2018-04-05       Impact factor: 4.944

Review 5.  Involvement of the myeloid cell compartment in fibrogenesis and systemic sclerosis.

Authors:  Gabriela Kania; Michal Rudnik; Oliver Distler
Journal:  Nat Rev Rheumatol       Date:  2019-05       Impact factor: 20.543

6.  The significance of macrophage polarization subtypes for animal models of tissue fibrosis and human fibrotic diseases.

Authors:  Peter J Wermuth; Sergio A Jimenez
Journal:  Clin Transl Med       Date:  2015-02-07

Review 7.  Update on the pathogenesis of Scleroderma: focus on circulating progenitor cells.

Authors:  Alexandra Maria Giovanna Brunasso; Cesare Massone
Journal:  F1000Res       Date:  2016-04-22

Review 8.  Caveolin-1 and Caveolin-2 Can Be Antagonistic Partners in Inflammation and Beyond.

Authors:  Cecília Jacques Gonçalves de Almeida
Journal:  Front Immunol       Date:  2017-11-17       Impact factor: 7.561

Review 9.  The Living Scar--Cardiac Fibroblasts and the Injured Heart.

Authors:  Eva A Rog-Zielinska; Russell A Norris; Peter Kohl; Roger Markwald
Journal:  Trends Mol Med       Date:  2016-01-14       Impact factor: 11.951

10.  Enhanced chemokine-receptor expression, function, and signaling in healthy African American and scleroderma-patient monocytes are regulated by caveolin-1.

Authors:  Rebecca Lee; Charles Reese; Beth Perry; Jonathan Heywood; Michael Bonner; Marina Zemskova; Richard M Silver; Stanley Hoffman; Elena Tourkina
Journal:  Fibrogenesis Tissue Repair       Date:  2015-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.